Dr. James Drakakis, DO

Dr. Drakakis practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Drakakis' NPI, 1285915322, was assigned on September 2, 2011. Dr. Drakakis graduated from LECOM at Seton Hill - Greensburg in 2007. Dr. Drakakis holds New York license 259283.

Dr. Drakakis' primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Drakakis' primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Drakakis is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Drakakis to 1 more hospital, 2 dialysis centers, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drakakis practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Drakakis' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Drakakis is board certified in internal medicine by the American Board of Internal Medicine. Dr. Drakakis is licensed in New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Drakakis treats.

CMS data shows 12,404 Medicare services from Dr. Drakakis across 13 procedure codes in 2024, for 872 Medicare patients. Medicare paid $358,140 for them.

CMS counts 872 Medicare patients who saw Dr. Drakakis in 2024. The largest group is 75 to 84, with 307 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Drakakis' median patient age at 66, with 44% women.

In 2024, Dr. Drakakis wrote 2,959 Medicare Part D claims for 413 patients. 86% of them were for generic drugs. CMS names the drug for 2,566 of them, across 64 drugs with 11 or more claims each, at $384,337 in total drug cost. In 2023, CMS named 2,481 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Drakakis for performance year 2024, reported as part of a group. Dr. Drakakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Drakakis as offering telehealth.

Dmand AI links 10 papers to Dr. Drakakis, published from 2012 to 2020. 2016 was the busiest year, with 4. Dr. Drakakis' most frequent co-authors are Louis J. Imbriano, MD, John K. Maesaka, MD and Naveed N. Masani, MD.

CMS Open Payments shows 3 general payments to Dr. Drakakis from 3 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $32.

Dr. Drakakis graduated from LECOM at Seton Hill - Greensburg in 2007.

Dr. Drakakis is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.